Get the Stockscreener App
5.85
1.92%
-0.15
Coya Therapeutics Inc stock is traded at $5.85, with a volume of 260.83K.
It is down -1.92% in the last 24 hours and down -3.53% over the past month.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
See More
Previous Close:
$6.00
Open:
$5.9
24h Volume:
260.83K
Relative Volume:
1.77
Market Cap:
$98.43M
Revenue:
-
Net Income/Loss:
$-14.88M
P/E Ratio:
-5.9694
EPS:
-0.98
Net Cash Flow:
$-10.29M
1W Performance:
-11.64%
1M Performance:
-3.53%
6M Performance:
-7.61%
1Y Performance:
-14.09%
1-Day Range:
$5.80
$6.20
1-Week Range:
$5.80
$6.77
52-Week Range:
$4.65
$8.29
Coya Therapeutics Inc Stock (COYA) Company Profile
Name
Coya Therapeutics Inc
Sector
Industry
Phone
650.739.3939
Address
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Compare COYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
5.885 | 125.55M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.08 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.47 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.04 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.22 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.50 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | D. Boral Capital | Buy |
Coya Therapeutics Inc Stock (COYA) Latest News
What indicators show strength in Coya Therapeutics Inc.2025 Market Overview & Accurate Buy Signal Alerts - newser.com
Coya Therapeutics Announces That Its Combination LD IL-2/GLP-1 RA Candidate (COYA 303) Demonstrated Potent Systemic and Brain Anti-Inflammatory Efficacy In Vivo - Eagle-Tribune
Is Coya Therapeutics Inc. meeting your algorithmic filter criteriaMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
Will Coya Therapeutics Inc. stock deliver better than expected guidanceJuly 2025 Reactions & Short-Term High Return Strategies - newser.com
Can Coya Therapeutics Inc. stock sustain revenue growthJuly 2025 Review & Weekly Watchlist for Consistent Profits - newser.com
What to do if you’re stuck in Coya Therapeutics Inc.Trade Risk Report & Fast Exit/Entry Strategy Plans - newser.com
Why Coya Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Price Swings & Short-Term Swing Trade Alerts - newser.com
What MACD signals say about Coya Therapeutics Inc.Earnings Overview Summary & AI Enhanced Trade Execution Alerts - newser.com
How to interpret RSI for Coya Therapeutics Inc. stockJuly 2025 Chart Watch & Daily Profit Maximizing Trade Tips - newser.com
Real time social sentiment graph for Coya Therapeutics Inc.GDP Growth & AI Forecast Swing Trade Picks - newser.com
Will Coya Therapeutics Inc. continue its uptrendGlobal Markets & Risk Adjusted Swing Trade Ideas - newser.com
What analyst consensus says on Coya Therapeutics Inc. stock2025 Key Lessons & Weekly Watchlist for Hot Stocks - newser.com
Coya Therapeutics Inc. stock trend outlook and recovery path2025 Trade Ideas & Verified Short-Term Plans - newser.com
Will Coya Therapeutics Inc. stock go up soonWeekly Profit Analysis & Weekly High Return Forecasts - newser.com
Will Coya Therapeutics Inc. stock split again soonIPO Watch & Expert Curated Trade Ideas - newser.com
Coya Therapeutics, Inc. (COYA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Why Coya Therapeutics Inc. stock remains resilient2025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Coya reports promising Alzheimer's treatment study results - MSN
Coya Therapeutics Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
How to build a custom watchlist for Coya Therapeutics Inc.2025 Price Action Summary & Community Driven Trade Alerts - newser.com
How Coya Therapeutics Inc. stock trades during market volatility2025 Big Picture & Entry and Exit Point Strategies - newser.com
Price momentum metrics for Coya Therapeutics Inc. explainedBull Run & Reliable Volume Spike Trade Alerts - newser.com
What drives Coya Therapeutics Inc stock priceEquity Performance Review & Low Cost Portfolio Ideas - earlytimes.in
Coya Therapeutics (COYA) Expected to Announce Earnings on Wednesday - MarketBeat
Coya Therapeutics Inc Stock (COYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Coya Therapeutics Inc Stock (COYA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SNYDER DAVID S | Chief Financial Officer |
Nov 14 '24 |
Buy |
7.19 |
1,800 |
12,934 |
8,800 |
| Swaminathan Arun | Chief Executive Officer |
Nov 13 '24 |
Buy |
7.36 |
5,000 |
36,797 |
10,000 |
| Grossman Fred | Chief Medical Officer |
Nov 11 '24 |
Buy |
7.37 |
2,710 |
19,973 |
2,710 |
| Swaminathan Arun | Chief Executive Officer |
Nov 11 '24 |
Buy |
7.34 |
5,000 |
36,689 |
5,000 |
1.02%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):